INFECTIOUS DNA VACCINES AGAINST CHIKUNGUNYA VIRUS
    7.
    发明授权
    INFECTIOUS DNA VACCINES AGAINST CHIKUNGUNYA VIRUS 有权
    感染性DNA疫苗对CHIKUNGUNYA病毒

    公开(公告)号:EP2519266B1

    公开(公告)日:2017-07-26

    申请号:EP11728540.3

    申请日:2011-01-03

    申请人: Medigen, Inc.

    IPC分类号: A61K39/12 C12N7/00

    摘要: Described herein are i-DNA™ vectors and vaccines and methods for using the same. The i-DNA™ generates live attenuated vaccines in eukaryotic cells in vitro or in vivo for pathogenic RNA viruses, particularly chikungunya virus (CHIKV). When iDNA is injected into the vaccine recipient, RNA of live attenuated virus is generated by in vivo transcription in the recipient's tissues. This initiates production of progeny attenuated viruses in the tissues of the vaccine recipient, as well as elicitation of an effective immune response protecting against wild-type, non-attenuated virus.

    摘要翻译: 本文描述了i-DNA™载体和疫苗以及使用它们的方法。 i-DNA™在真核细胞中体外或体内产生致病RNA病毒,特别是基孔肯雅病毒(CHIKV)的减毒活疫苗。 当iDNA被注射到疫苗接受者体内时,活的减毒病毒的RNA通过在受体组织中的体内转录产生。 这启动了疫苗接受者组织中子代减毒病毒的产生,以及引发针对野生型非减毒病毒的有效免疫应答。